» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.

Similar documents
BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

MONOGRAPHS (USP) Saccharin Sodium

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

Change to read: BRIEFING

BRIEFING Assay + + +

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Identification B Identification C + + +

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

BRIEFING. 1. Definition Changed to include only Wheat Starch, as to conform to the individual monograph for Wheat Starch.

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB

Petrolatum. Stage 4, Revision 1. Petrolatum is a purified semi solid mixture of hydrocarbons obtained from petroleum.

BRIEFING. Nonharmonized attributes: Characters, Microbial Enumeration Tests, and Tests for Specified Microorganisms, and Packing and Storage (USP)

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB1886.

Draft proposal for The International Pharmacopoeia

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

6.02 Uniformity of Dosage Units

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

HYDROXYPROPYLCELLULOSE, LOW SUBSTITUTED Stage 4, Revision 1 CP: USP BRIEFING NOTE

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

contents of the monograph in effect today. Please refer to the current edition of the USP NF for official text.

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

INTERIM REVISION ANNOUNCEMENT

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

GB Translated English of Chinese Standard: GB NATIONAL STANDARD

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

Purity Tests for Modified Starches

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

Hydroxypropyl Starch (Tentative)

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN THE FOURTH EDITION OF The International Pharmacopoeia

Official Journal of the European Union REGULATIONS

Feedstuffs Analysis G-22-1 PROTEIN

E17 ETHYLCELLULOSE. Revision 3 Stage 4

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

Diltiazem Hydrochloride Extended-Release Capsules. Type of Posting Posting Date Official Date

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

Revision Bulletin 23 Feb Mar 2018 Chemical Medicines Monographs 3 Compliance

Final text for addition to The International Pharmacopoeia (June 2010)

Amendment of Standards for Specification, Scope, Application and Limitation of Food Additives

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

Heparin Sodium ヘパリンナトリウム

Corn Starch Analysis B-47-1 PHOSPHORUS

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

European Pharmacopoeia solutions

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

INTERNATIONAL ŒNOLOGICAL CODEX. PROTEIN PLANT ORIGIN FROM WHEAT, PEAS and POTATOES (OENO 28/2004, ) OIV-OENO OIV-OENO

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

Compliance. Minor editorial changes have been made to update the monograph to the current USP style.

Tramadol Hydrochloride Extended-Release Tablets. Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance

THERMALLY OXIDIZED SOYA BEAN OIL

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

Nitrate and Nitrite Key Words: 1. Introduction 1.1. Nature, Mechanism of Action, and Biological Effects (Fig. 1)

1 out of 8. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 86th Meeting 2018 ERYTHROSINE

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

B - Barium chloride (0.1 mol/l) VS... Butylated hydroxytoluene R

TENOFOVIRI DISOPROXILIS FUMARAS TENOFOVIR DISOPROXIL FUMARATE

DRAFT EAST AFRICAN STANDARD

Revisions to USP 31 NF 26, Second Supplement

PHCH 402: Analytical Quality Control Different methods of analysis of some groups of drugs in common use in Nigeria (8 hrs)

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

E55A GELATIN, GELLING GRADE Gelatina

SOUTH AFRICAN NATIONAL STANDARD

Minor editorial changes have been made to update the monograph to the current USP style.

Student Practical Guide (1) Milk of Magnesia

II-C- CHECKING RAW MATERIALS

21 Virginiamycin OH O. For chickens (except for broilers) broilers. Added amount 5~15 5~15 10~20 10~20

4. Determination of fat content (AOAC, 2000) Reagents

COMMENTARY TO USP31 - NF26

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

By Authority Of THE UNITED STATES OF AMERICA Legally Binding Document

Telmisartan and Hydrochlorothiazide Tablets. Type of Posting. Revision Bulletin Posting Date. 26 Jan 2018 Official Date

Should you have any questions, please contact Gerald Hsu, Ph.D., Senior Scientific Liaison ( or

Draft Indian Standard SODIUM HYDROXIDE, FOOD GRADE SPECIFICATION

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

Hydroponics TEST KIT MODEL AM-41 CODE 5406

Chemical Pharmaceutical Quality Control. Prof.Dr.Joumaa Al- Zehouri Damascus university Faculty of Pharmacy

Lutein Esters from Tagetes Erecta

Hardness, Total, Sequential

B. 1% (w/v) Salicin Substrate Solution (Salicin) (Prepare 50 ml in Reagent A using Salicin, Sigma Prod. No. S-0625.)

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016)

The International Pharmacopoeia TENOFOVIR DISOPROXIL FUMARATE (JULY 2012)

Enzymatic Assay of POLYGALACTURONASE (EC )

Instruction Manual Updated 8/27/2013 Ver. 1.1

Labetalol Hydrochloride. Official Monographs / Labetalol Hydrochloride. labetalol hydrochloride (C 19 H 24 N 2 O 3.HCl).

INTERNATIONAL ŒNOLOGICAL CODEX. BENTONITES Bentonita N SIN: 558 (Oeno 11/2003 modified Oeno )

Yeast, Autolyzed. a dry place.

CHAPTER 3: MATERIALS AND METHODS

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

Transcription:

BRIEFING Citric Acid, Monohydrate. The European Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the Citric Acid, Monohydrate monograph, as part of the process of international harmonization of monographs and general analytical methods of the European, Japanese, and United States pharmacopeias. The following monograph, which represents the ADOPTION STAGE 6 document, is based on the corresponding monograph for Citric Acid, Monohydrate that was prepared by the European Pharmacopoeia. The European Pharmacopoeia draft was based in part on comments from the Japanese Pharmacopoeia and the United States Pharmacopeia in response to the Provisional Harmonized Text Stage 5A and 5B drafts prepared by the European Pharmacopoeia. The current USP monograph for Citric Acid will be replaced with two separate monographs for Citric Acid, Anhydrous and Citric Acid, Monohydrate. Differences between the European Pharmacopoeia Adoption Stage 6 document and the current USP monograph for Citric Acid include the following: 1. Definition Changed to include only Citric Acid, Monohydrate, as to conform to the individual monograph for Citric Acid, Monohydrate. 2. Labeling The indication of anhydrous or hydrous is deleted, as to conform to the individual monograph for Citric Acid, Monohydrate. A requirement that the label indicate where it is intended for use in dialysis solutions is added. 3. USP Reference standards A Citric Acid reference standard to be used with the Identification test is added. 4. Clarity of solution This test is added in order to conform with EP standards. 5. Color of solution This test is added in order to conform with EP standards. 6. Identification The test for Citrate is deleted and a more definitive infrared absorption test is added. 7. Water The standard for this test is changed from not more than 8.8% to a range of 7.5% to 9.0% in order to conform with EP standards. 8. Residue on ignition The standard for this test is increased from 0.05% to 0.1% in order to conform with JP standards. 9. Readily carbonizable substances No change. 10. Sulfate The test procedure is changed to a quantitative test in order to conform to EP standards. 11. Arsenic This test is deleted because the Heavy metals test sufficiently accounts for arsenic. 12. Heavy metals No change. 13. Limit of oxalic acid The test procedure is changed to a quantitative test in order to conform to EP standards. 14. Limit of aluminum This test is added in order to conform with EP standards concerning usage in dialysis. This requirement is similar to the Limit of aluminum in the USP Calcium Acetate monograph. 15. Organic volatile impurities No change. 16. Assay The sample size is decreased from 3 g in 40 ml of water to 0.55 g in 50 ml of water. The amount of Citric Acid that is equivalent to 1 ml of 1 N sodium hydroxide is changed from 64.04 mg to a more accurate 64.03 mg. (EMC: J. Lane ) RTS 36456 1 http://www.usppf.com/pf/pub/index.html 1/5

Add the following: Citric Acid, Monohydrate (Chemical structure to come) C 6 H 8 O 7 H 2 O 210.14 1,2,3 Propanetricarboxylic acid, 2 hydroxy, monohydrate [5949 29 1].» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.5 percent of C 6 H 8 O 7, calculated on the anhydrous basis. Packaging and storage Preserve in tight containers. Labeling Where it is intended for use in dialysis solutions, it is so labeled. USP Reference standards 11 USP Citric Acid RS. Clarity of solution [ NOTE The Test solution is to be compared to Reference suspension A in diffused daylight 5 minutes after preparation of Reference suspension A. ] Hydrazine sulfate solution Transfer 1.0 g of hydrazine sulfate to a 100 ml volumetric flask, dissolve in and dilute with water to volume, and mix. Allow to stand for 4 to 6 hours before use. Hexamethylenetetramine solution Transfer 2.5 g of Hexamethylenetetramine to a 100 ml glass stoppered flask, add 25.0 ml of water, insert the glass stopper, and mix to dissolve. Primary opalescent suspension [ NOTE This suspension is stable for 2 months, provided it is stored in a glass container free from surface defects. The suspension must not adhere to the glass and must be well mixed before use. ] Transfer 25.0 ml of Hydrazine sulfate solution to the Hexamethylenetetramine solution in the 100 ml glass stoppered flask. Mix, and allow to stand for 24 hours. Opalescence standard [ NOTE This suspension should not be used beyond 24 hours after preparation. ] Transfer 15.0 ml of the Primary opalescent suspension to a 1000 ml volumetric flask, dilute with water to volume, and mix. Reference suspensions Transfer 5.0 ml of the Opalescence standard to a 100 ml volumetric flask, dilute with water to volume, and mix to obtain Reference suspension A. Transfer 10.0 ml of the Opalescence standard to a second 100 ml volumetric flask, dilute with water to volume, and mix to obtain Reference suspension B. Test solution Dissolve 2.0 g of Citric Acid in about 5 ml of water, dilute with water to 10 ml, and mix. Procedure Transfer a sufficient portion of the Test solution to a test tube of colorless, transparent, neutral glass with a flat base and an internal diameter of 15 to 25 mm to obtain a depth of 40 mm. Similarly transfer portions of Reference suspension A, Reference suspension B, and water to separate matching test tubes. Compare the Test solution, Reference suspension A, Reference suspension B, and water in http://www.usppf.com/pf/pub/index.html 2/5

diffused daylight, viewing vertically against a black background (see Visual Comparison under Spectrophotometry and Light Scattering 851 ). [ NOTE The diffusion of light must be such that Reference suspension A can readily be distinguished from water, and that Reference suspension B can readily be distinguished from Reference suspension A. ] The Test solution shows the same clarity as that of water. Color of solution Standard stock solutions Prepare three solutions, A, B, and C, containing, respectively, the following parts of ferric chloride CS, cobaltous chloride CS, cupric sulfate CS, and dilute hydrochloric acid (10 g/l): A 2.4:0.6:0:7.0 B 2.4:1.0:0.4:6.2 C 9.6:0.2:0.2:0 Standard solutions [ NOTE Prepare the Standard solutions immediately before use. ] Transfer 2.5 ml of Standard stock solution A to a 100 ml volumetric flask, dilute with dilute hydrochloric acid (10 g/l) to volume, and mix to obtain Standard solution A. Transfer 2.5 ml of Standard stock solution B to a 100 ml volumetric flask, dilute with dilute hydrochloric acid (10 g/l) to volume, and mix to obtain Standard solution B. Transfer 0.75 ml of Standard stock solution C to a 100 ml volumetric flask, dilute with dilute hydrochloric acid (10 g/l) to volume, and mix to obtain Standard solution C. Test solution Use the Test solution prepared in the Clarity of solution test. Procedure Transfer a sufficient portion of the Test solution to a test tube of colorless, transparent, neutral glass with a flat base and an internal diameter of 15 to 25 mm to obtain a depth of 40 mm. Similarly transfer portions of Standard solution A, Standard solution B, and Standard solution C to separate matching test tubes. Compare the Test solution, Standard solution A, Standard solution B, and Standard solution C in diffused daylight, viewing vertically against a white background (see Visual Comparison under Spectrophotometry and Light Scattering 851 ). The Test solution is not more intensely colored than Standard solutions A, B, and C. Identification, Infrared Absorption 197K. Bacterial endotoxins test 85 If intended for use in the manufacturing of parenteral dosage forms, without a further appropriate procedure for the removal of bacterial endotoxins, not more than 0.5 I.U. of endotoxin per milligram. Water, Method I 921 : between 7.5% and 9.0%. Residue on ignition 281 : not more than 0.1%, determined on 1.0 g. Readily carbonizable substances Transfer 1.0 g, powdered for the test, to a 22 175 mm test tube previously rinsed with 10 ml of sulfuric acid TS and allowed to drain for 10 minutes. Add 10 ml of sulfuric acid TS, agitate until solution is complete, and immerse in a water bath at 90 ± 1º for 60 ± 0.5 minutes, keeping the level of the acid below the level of the water during the entire period. Cool the tube in running water, and transfer the acid to a color comparison tube: the color of the acid is not darker than that of a similar volume of Matching Fluid K (see Color and Achromicity 631 ) in a matching tube, the tubes being observed vertically against a white background. Sulfate http://www.usppf.com/pf/pub/index.html 3/5

Standard sulfate solution A To 181 mg of dibasic potassium sulfate in a 100 ml volumetric flask, add a few ml of 30 percent alcohol, swirl to dissolve, dilute with 30 percent alcohol to volume, and mix. Immediately before use, transfer 10.0 ml of this solution to a 1000 ml volumetric flask, dilute with 30 percent alcohol to volume, and mix. This solution contains 10 µg of sulfate per ml. Standard sulfate solution B To 181 mg of dibasic potassium sulfate in a 100 ml volumetric flask, add a few ml of water, swirl to dissolve, dilute with water to volume, and mix. Immediately before use, transfer 10.0 ml of this solution to a 1000 ml volumetric flask, dilute with water to volume, and mix. This solution contains 10 µg of sulfate per ml. Citric acid solution Dissolve 2.0 g of Citric Acid in about 10 ml of water, dilute with water to 30 ml, and mix. Procedure To 4.5 ml of Standard sulfate solution A add 3 ml of a barium chloride solution (1 in 4), shake, and allow to stand for 1 minute. To 2.5 ml of the resulting suspension, add 15 ml of the Citric acid solution and 0.5 ml of 5 N acetic acid, and mix (Test solution). Prepare the Standard solution in the same manner, except use 15 ml of Standard sulfate solution B instead of the Citric acid solution: any turbidity produced in the Test solution after 5 minutes standing is not greater than that produced in the Standard solution (0.015%). Heavy metals 231 : 0.001%. Limit of oxalic acid Prepare a citric acid solution by dissolving 800 mg of Citric Acid in 4 ml of water. Add 3 ml of hydrochloric acid and 1 g of granular zinc, boil for 1 minute, and allow to stand for 2 minutes. Transfer the supernatant to a test tube containing 0.25 ml of a phenylhydrazine hydrochloride solution (1 in 100), and heat to boiling. Cool rapidly, transfer to a graduated cylinder, and add an equal volume of hydrochloric acid and 0.25 ml of a potassium ferricyanide solution (1 in 20). Shake, and allow to stand for 30 minutes (Test solution). Concomitantly prepare a control solution in the same manner, except use 4 ml of an oxalic acid solution containing 0.10 mg per ml, equivalent to 0.0714 mg of anhydrous oxalic acid per ml, instead of the citric acid solution: any pink color produced in the Test solution is not more intense than that produced in the control solution (0.036%). Limit of aluminum (where it is labeled as intended for use in dialysis) Standard aluminum solution To 352 mg of aluminum potassium sulfate in a 100 ml volumetric flask, add a few ml of water, swirl to dissolve, add 10 ml of diluted sulfuric acid, dilute with water to volume, and mix. Immediately before use, transfer 1.0 ml of this solution to a 100 ml volumetric flask, dilute with water to volume, and mix. ph 6.0 acetate buffer Dissolve 50 g of ammonium acetate in 150 ml of water, adjust with glacial acetic acid to a ph of 6.0, dilute with water to 250 ml, and mix. Test solution Dissolve 20.0 g of Citric Acid in 100 ml of water, and add 10 ml of ph 6.0 acetate buffer. Extract this solution with successive portions of 20, 20, and 10 ml of a 0.5% solution of 8 hydroxyquinoline in chloroform, combining the chloroform extracts in a 50 ml volumetric flask. Dilute the combined extracts with chloroform to volume, and mix. Standard solution Prepare a mixture of 2.0 ml of Standard aluminum solution, 10 ml of ph 6.0 acetate buffer, and 98 ml of water. Extract this mixture as described for the Test solution, dilute the combined extracts with chloroform to volume, and mix. Blank solution Prepare a mixture of 10 ml of ph 6.0 acetate buffer and 100 ml of water. Extract this mixture as described for the Test solution, dilute the combined extracts with chloroform to volume, and mix. http://www.usppf.com/pf/pub/index.html 4/5

Procedure Determine the fluorescence intensities of the Test solution and the Standard solution in a fluorometer set at an excitation wavelength of 392 nm and an emission wavelength of 518 nm, using the Blank solution to set the instrument to zero. The fluorescence of the Test solution does not exceed that of the Standard solution (0.2 µg per g). Organic volatile impurities, Method IV 467 : meets the requirements. Assay Place about 0.550 g of Citric Acid in a tared flask, and weigh accurately. Dissolve in 50 ml of water, add 0.5 ml of phenolphthalein TS, and titrate with 1 N sodium hydroxide VS. Each ml of 1 N sodium hydroxide is equivalent to 64.03 mg of C 6 H 8 O 7. Auxiliary Information Staff Liaison : Justin Lane, B.S., Senior Scientific Associate Expert Committee : (EMC) Excipients: Monograph Content Phone Number : 1 301 816 8323 1 http://www.usppf.com/pf/pub/index.html 5/5